This listing includes new single chemical entities and preparations, duplicate single products, and combination products that have been made available for clinical use by the U.S. Food and Drug Administration during the period from September 21 to November 21, 1972. This information is taken from the manufacturer's package insert or brochure, which should be consulted for further details on indications, dosage, contraindications, and adverse reactions.